Cargando…
Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic
PURPOSE: Cancer patients have many medical and psychosocial needs, which may increase during the COVID-19 pandemic. We sought to (1) risk-stratify hematology/oncology patients using general medicine and cancer-specific methods to identify those at high risk for acute care utilization, (2) measure th...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549726/ https://www.ncbi.nlm.nih.gov/pubmed/33047163 http://dx.doi.org/10.1007/s00520-020-05744-y |
_version_ | 1783592836128571392 |
---|---|
author | Osterman, Chelsea K. Triglianos, Tammy Winzelberg, Gary S. Nichols, Angela D. Rodriguez-O’Donnell, Julia Bigelow, Sharon M. van Deventer, Hendrik Sanoff, Hanna K. Ray, Emily M. |
author_facet | Osterman, Chelsea K. Triglianos, Tammy Winzelberg, Gary S. Nichols, Angela D. Rodriguez-O’Donnell, Julia Bigelow, Sharon M. van Deventer, Hendrik Sanoff, Hanna K. Ray, Emily M. |
author_sort | Osterman, Chelsea K. |
collection | PubMed |
description | PURPOSE: Cancer patients have many medical and psychosocial needs, which may increase during the COVID-19 pandemic. We sought to (1) risk-stratify hematology/oncology patients using general medicine and cancer-specific methods to identify those at high risk for acute care utilization, (2) measure the correlation between two risk stratification methods, and (3) perform a telephone-based needs assessment with intervention for high-risk patients. METHODS: Patients were risk-stratified using a general medical health composite score (HCS) and a cancer-specific risk (CSR) stratification based on disease and treatment characteristics. The correlation between HCS and CSR was measured using Spearman’s correlation. A multi-disciplinary team developed a focused needs assessment script with recommended interventions for patients categorized as high-risk by either method. The number of patient needs identified and referrals for services made in the first month of outreach are reported. RESULTS: A total of 1697 patients were risk-stratified, with 17% high-risk using HCS and 22% high-risk using CSR. Correlation between HCS and CSR was modest (ρ = 0.41). During the first month of the pilot, 286 patients were called for outreach with 245 contacted (86%). Commonly identified needs were financial difficulties (17%), uncontrolled symptoms (15%), and interest in advance care planning (13%), resulting in referral for supportive services for 33% of patients. CONCLUSION: There is a high burden of unmet medical and psychosocial needs in hematology/oncology patients during the COVID-19 pandemic. A telephone-based outreach program results in the identification of and intervention for these needs; however, additional cancer-specific risk models are needed to improve targeting to high-risk patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05744-y) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-7549726 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-75497262020-10-14 Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic Osterman, Chelsea K. Triglianos, Tammy Winzelberg, Gary S. Nichols, Angela D. Rodriguez-O’Donnell, Julia Bigelow, Sharon M. van Deventer, Hendrik Sanoff, Hanna K. Ray, Emily M. Support Care Cancer Commentary PURPOSE: Cancer patients have many medical and psychosocial needs, which may increase during the COVID-19 pandemic. We sought to (1) risk-stratify hematology/oncology patients using general medicine and cancer-specific methods to identify those at high risk for acute care utilization, (2) measure the correlation between two risk stratification methods, and (3) perform a telephone-based needs assessment with intervention for high-risk patients. METHODS: Patients were risk-stratified using a general medical health composite score (HCS) and a cancer-specific risk (CSR) stratification based on disease and treatment characteristics. The correlation between HCS and CSR was measured using Spearman’s correlation. A multi-disciplinary team developed a focused needs assessment script with recommended interventions for patients categorized as high-risk by either method. The number of patient needs identified and referrals for services made in the first month of outreach are reported. RESULTS: A total of 1697 patients were risk-stratified, with 17% high-risk using HCS and 22% high-risk using CSR. Correlation between HCS and CSR was modest (ρ = 0.41). During the first month of the pilot, 286 patients were called for outreach with 245 contacted (86%). Commonly identified needs were financial difficulties (17%), uncontrolled symptoms (15%), and interest in advance care planning (13%), resulting in referral for supportive services for 33% of patients. CONCLUSION: There is a high burden of unmet medical and psychosocial needs in hematology/oncology patients during the COVID-19 pandemic. A telephone-based outreach program results in the identification of and intervention for these needs; however, additional cancer-specific risk models are needed to improve targeting to high-risk patients. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00520-020-05744-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-10-12 2021 /pmc/articles/PMC7549726/ /pubmed/33047163 http://dx.doi.org/10.1007/s00520-020-05744-y Text en © Springer-Verlag GmbH Germany, part of Springer Nature 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Commentary Osterman, Chelsea K. Triglianos, Tammy Winzelberg, Gary S. Nichols, Angela D. Rodriguez-O’Donnell, Julia Bigelow, Sharon M. van Deventer, Hendrik Sanoff, Hanna K. Ray, Emily M. Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title | Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title_full | Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title_fullStr | Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title_full_unstemmed | Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title_short | Risk stratification and outreach to hematology/oncology patients during the COVID-19 pandemic |
title_sort | risk stratification and outreach to hematology/oncology patients during the covid-19 pandemic |
topic | Commentary |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7549726/ https://www.ncbi.nlm.nih.gov/pubmed/33047163 http://dx.doi.org/10.1007/s00520-020-05744-y |
work_keys_str_mv | AT ostermanchelseak riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT triglianostammy riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT winzelberggarys riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT nicholsangelad riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT rodriguezodonnelljulia riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT bigelowsharonm riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT vandeventerhendrik riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT sanoffhannak riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic AT rayemilym riskstratificationandoutreachtohematologyoncologypatientsduringthecovid19pandemic |